ATOS Stock Price: Atossa Therapeutics Inc extends rally on FDA Letter for cancer treatment Home > Business > Article
3 years ago By Lawce — NASDAQ:ATOS continued its week-long run as the stock has already gained nearly 80% since Monday, and it has shown no signs of slowing down. On Thursda
#atosstockprice #atossatherapeuticsinc #fda